Navigation Links
Rising Incidence of Chronic Diseases in Children Drives the Pediatric Drugs and Vaccines Market, According to an Upcoming Report by Global Industry Analysts, Inc.
Date:7/21/2014

San Jose, California (PRWEB) July 21, 2014

Follow us on LinkedIn – GIA is pleased to announce the launch of a major research program analysing the trends impacting the market for “Pediatric Drugs and Vaccines”. Invited to participate in this comprehensive grassroots level global research initiative are senior industry executives, domain experts, technologists and market strategists. The new report to be issued shortly will offer accurate assessment of global market developments including major technologies, trends and challenges, together with descriptive, exploratory, and quantitative analysis of major product and geographic market segments. For details about participation in this primary research program to include your inputs prior to the publication, please click here.

Rise in chronic health conditions in children represents a major factor fuelling demand for pediatric drugs and vaccines. Poor dietary habits, sedentary lifestyles, and lack of exercise are resulting in increased prevalence of obesity, asthma, diabetes, behavioural and learning problems in children. Huge unmet medical needs in this market juxtaposed with saturating market opportunities in geriatric pharmaceuticals, is resulting in a large number of pharmaceutical companies shifting focus to pediatric drug development. Federal level recognition and acceptance of distinct therapeutic needs for pediatric patients is playing an instrumental role in encouraging pediatric drug development programs. Additionally, in an attempt to encourage manufacturers to perform clinical trials for the pediatric population, the FDA and EMA are adopting new regulations and policies. Developments in preclinical safety assessment, better understanding of pharmacological principles in pediatric drug development, and stringent formulation, chemistry, and manufacturing controls, will benefit the development of successful clinical therapeutics for this vulnerable patient population. Future growth in the market will come from pediatric vaccines, hormone therapy drugs, respiratory & allergy drugs, CNS drugs, and anti-infective drugs. Further, sales of other drugs including anti-obesity medicines are expected to grow, following their approval for pediatric use.

The upcoming report will offer coverage on major companies including Abbott Laboratories, GlaxoSmithKline Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi, among others.

In addition, the study will also provide:

  • Valuable market based intelligence on new emerging trends, growth drivers, issues and challenges.
  • Current coverage on company information and latest news and events including strategic corporate developments, and product innovations
  • Fresh research perspectives, statistical findings, analyst analysis, and commentaries
  • Accurate market estimates, projections, and forecasts across therapeutic segments (Pediatric Vaccines, Pediatric Hormones, Allergy &Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other) and major geographic markets (the United States, Europe, Asia-Pacific, Latin America, and Rest of World).

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/pediatric_drugs_market/pediatric_vaccines/prweb12032702.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. Surgery Rates Rising for Non-Melanoma Skin Cancer: Study
3. Catastrophic Head Injuries to High School Football Players Rising
4. Surprising results for use of dialysis for kidney failure in developing world
5. Rising Obesity Rates Might Mean More Rheumatoid Arthritis
6. Life-saving primary PCI rising in Stent for Life countries
7. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
8. Discount Supermarkets Tied to Rising Obesity Rates
9. Rising Solar Engineering and Design Firm Enters 1.7 MW's in Connecticut ZREC Auction and Positions for Future Growth
10. Spending on childrens health rising faster than adults over past 4 years, says report
11. Generation X is surprisingly unconcerned about climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Viejo, CA (PRWEB) , ... February 18, 2017 ... ... animating paragraph presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume ... descriptions, and so many other applications. Users can pick and choose from ...
(Date:2/17/2017)... ... 2017 , ... While EHR data has revolutionized the nursing ... workstation designed to reduce nursing fatigue while enhancing productivity. Based on field experience ... lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. , Nurses ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the first ... solution to the exhibit floor for the 2017 HIMSS Conference & Exhibition ... Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive Action ... Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd ... preventive action (PA)? , The methods share techniques and tools but they are ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... by fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced ... Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 According to ... Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of ... to 2021" published by MarketsandMarkets, the market is expected to reach ... at a CAGR of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... DUBLIN , Feb. 17, 2017  Perrigo Company plc (NYSE, ... the U.S. Food and Drug Administration for hydrocodone bitartrate and ... mL. Hydrocodone bitartrate and homatropine methylbromide oral ... for the symptomatic relief of cough in adults and children ... 12 months ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... YORK , Feb. 17, 2017   Risperdal ... side effects allegedly associated with use of the atypical ... Philadelphia Court of Common Pleas, where ... mass tort program. According to a notice posted on ... to convene a meeting on March 9, 2017 at ...
Breaking Medicine Technology: